There have been documented interactions between the cholesterol-lowering medication Lipitor (atorvastatin) and Selective Serotonin Reuptake Inhibitors (SSRIs). SSRIs are a type of antidepressant commonly used to treat depression, anxiety, and other mood disorders.

According to DrugPatentWatch.com [1], Lipitor can increase the levels of SSRIs in the blood, potentially leading to increased side effects such as serotonin syndrome. Serotonin syndrome is a potentially life-threatening condition caused by excessive levels of serotonin in the body.

A study published in the Journal of Clinical Psychopharmacology found that concomitant use of atorvastatin and SSRIs, including fluoxetine (Prozac), sertraline (Zoloft), and paroxetine (Paxil), increased the risk of serotonin syndrome [2].

Another study published in the European Journal of Clinical Pharmacology found that atorvastatin increased the plasma concentrations of citalopram (Celexa), a type of SSRI, in healthy subjects [3].

It is essential to note that these interactions can be managed by monitoring patients for signs of serotonin syndrome and adjusting the dose or switching medications if necessary. Healthcare professionals should be aware of these potential interactions and take steps to minimize the risk of adverse effects.

Sources:

[1] DrugPatentWatch.com (accessed 2023-12-01)

[2] Journal of Clinical Psychopharmacology, "Serotonin syndrome associated with concomitant use of atorvastatin and selective serotonin reuptake inhibitors" (2009)

[3] European Journal of Clinical Pharmacology, "Atorvastatin increases the plasma concentrations of citalopram" (2010)

Sources:

1. https://www.drugpatentwatch.com/
2. https://journals.lww.com/jclinpsychopharmacology/Fulltext/2009/05000/SerotoninSyndromeAssociatedWithConcomitant_Use.17.aspx
3. https://pubmed.ncbi.nlm.nih.gov/20355167/